It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has ...

On Thursday, Jim Cramer, the host of Mad Money, discussed the recent turbulence in the stock market, pointing to the lack of ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

In this article, we will take a look into Eli Lilly and Co's (NYSE:LLY) DCF analysis, a reliable and data-driven approach to ...

While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. Lone Pine Capital, established in 1997 by Stephen Mandel, is a leading hedge ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

It is tailored to patients being treated with Lilly's oncology drugs – which ... the negative side effects of treatment," said the company's chief executive Dr Tryggvi Thorgeirsson.

Eli Lilly has launched a new website-based access ... approach in which a patient’s prescription goes straight to the company, and is also notable as it bundles in telehealth access to doctors ...

Eli Lilly is investing $27 billion in U.S. manufacturing to expand drug production and secure future supply. The company will ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...